November 17, 2017 12:36 PM ET


Company Overview of Oncoral Pharma ApS

Company Overview

Oncoral Pharma ApS develops pharmaceutical preparation for the treatment of colon and rectal cancer patients. The company was founded in 2013 and is headquartered in Ballerup, Denmark. As of September 14, 2017, Oncoral Pharma ApS operates as a subsidiary of CMC Contrast AB.

Energivej 42

Ballerup,  2750


Founded in 2013

Key Executives for Oncoral Pharma ApS

Oncoral Pharma ApS does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
7TM Pharma A/S Europe
Acesion Pharma ApS Europe
Action Pharma A/S Europe
Adenium Biotech ApS Europe
Alkalon A/S Europe

Recent Private Companies Transactions

September 14, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oncoral Pharma ApS, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at